Dyce Sombre – Psychiatry in history

appropriate) with clinical assessment and the use of other innovations such as computerised cognitive testing, blood-based biomarkers and data from wearable devices.Studies of ULF-MRI in memory clinic populations will determine whether it will become a much-needed disruptor of our current dementia assessment pathways.The advances in this technology are timely in the context of the increase in demand for dementia assessment and developments in disease-modifying treatments for patients with Alzheimer's disease.The potential of ULF-MRI for monitoring amyloid-related imaging abnormalities related to these treatments is another critical question.